Pirtobrutinib | CAS 2101700-15-4 - Request Quote
Pirtobrutinib
| SZ CAT No: | SZ-P208001 |
| CAS No | 2101700-15-4 |
| Mol.F. | C22H21F4N5O3 |
| Mol.Wt. | 479.4 |
| Inv. Status | Synthesis on demand |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Pirtobrutinib is chemically (S)-5-Amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide. Pirtobrutinib is supplied with detailed characterization data compliant with regulatory guideline. Pirtobrutinib can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pirtobrutinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2101700-15-4
Purchase 2101700-15-4
Order 2101700-15-4
Enquire 2101700-15-4
price of 2101700-15-4
2101700-15-4 Supplier
2101700-15-4 Manufacturer
2101700-15-4 Exporter
buy high quality Pirtobrutinib
Purchase Pirtobrutinib
Pirtobrutinib suppliers
Pirtobrutinib manufacturers
Pirtobrutinib price
Order Pirtobrutinib
Enquire Pirtobrutinib
Pirtobrutinib cost
Pirtobrutinib Supplier
Pirtobrutinib Distributor
Pirtobrutinib for Method Validation
Pirtobrutinib Reference Standard
Pirtobrutinib for ANDA Filing
Pirtobrutinib for Forced Degradation Studies
Pirtobrutinib Identification Standards
Pirtobrutinib for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


